Acurx Pharmaceuticals (ACXP) Tops Q1 EPS by 7c

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q1 EPS of ($0.26), $0.07 better than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Medtronic completes $550 million Scientia Vascular acquisition
• United Community Banks sells equipment finance unit for $1.9 billion